Concepedia
2
Publications
383
Citations
H-Index
2017
Active since
Affiliations
Eureka Therapeutics (United States)(Current)
Memorial Sloan Kettering Cancer Center
Kim Harrington is an author at Eureka Therapeutics (United States).
Publications per year
2017–2019
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
Eric L. Smith, Kim Harrington, Reed Masakayan et al. · Science Translational Medicine · 2019 · 373 citations · Full text
Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma
Kim Harrington, Rebecca Wu, Collin Hauskins et al. · Blood · 2017 · 10 citations
Rows per page
1–2 of 2